You will grow through what you go through. It sounds like one of those motivational platitudes spouted at high speed on whatever social networking platform you choose to frequent,…
Research
Inmed Pharmaceuticals (IN.T) filed a patent co-operation treaty (PCT) application relating to the potential for cannabinoids to prevent neuron damage associated with glaucoma. The patent application is called “Compositions…
New licenses, deals, products – that’s all good – but it’s not the nitty gritty stuff investors are looking for now.
By “nitty-gritty” we mean – numbers.
Four weeks ago, Heritage…
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple…
Medipharm Labs (LABS.T) completed its first shipment of bottled cannabis topicals under a contract manufacturing agreement, and accelerated their research and development program to expand the company’s presence in…
Puration (PURA.Q) verified their intention to acquire Kali Extracts (KALY.OTC) subsidiary, Kaly CBD Confection Operations earlier this week. KALY is concentrating on its cannabis extracts biopharmaceutical business. Their research…
Xphyto Therapeutics (XPHY.C) German subsidiary Vektor Pharma TF GmbH will commence several research and development programs related to infectious disease, including thin film delivery of cannabigerol (CBG) and quercetic…
The United States Patent and Trademark Office granted Nextleaf Solutions (OILS.C) their patent for the acetylation of cannabinoids today. The patent describes a process to refine delta 9-tetrahydrocannabinol (or…
Tetra Biopharma (TBP.V) has been busy conducting clinical development programs of two potential products, the first being Quixleef and the second Plenitude. Both involve dealing with uncontrolled pain in…
Xphyto (XPHY.C) is dominating the cannabis sector like Sean Kemp used to dominate the Seattle buffet scene. It’s a legit beast right now, jumping from fat new high to…